3,513
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway

, , &
Pages 329-335 | Received 17 Mar 2017, Accepted 07 Oct 2017, Published online: 02 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Elizabeth B. Matthews & Ayse Akincigil. (2022) The impact of electronic health record functions on patterns of depression treatment in primary care. Informatics for Health and Social Care 47:3, pages 295-304.
Read now
Aalto Ulla L, Rantsi Mervi, Juola Anna-Liisa, Kautiainen Hannu & Pitkälä Kaisu H. (2022) The effect of educational intervention on use of psychotropics in defined daily doses and related costs – a randomized controlled trial. Scandinavian Journal of Primary Health Care 40:2, pages 246-252.
Read now
Aud Johannessen, Kjerstin Tevik, Knut Engedal, Gro Gade Haanes & Anne-Sofie Helvik. (2021) Health Professionals’ Experiences Regarding Alcohol Consumption and Its Relation to Older Care Recipient’s Health and Well-Being. Journal of Multidisciplinary Healthcare 14, pages 1829-1842.
Read now
Siri A. Devik, Rose Mari Olsen, Inger Lise Fiskvik, Terje Halbostad, Tone Lassen, Natalia Kuzina & Ingela Enmarker. (2018) Variations in drug-related problems detected by multidisciplinary teams in Norwegian nursing homes and home nursing care. Scandinavian Journal of Primary Health Care 36:3, pages 291-299.
Read now

Articles from other publishers (29)

Maria Torheim Bjelkarøy, Tone Breines Simonsen, Tahreem Ghazal Siddiqui,Socheat Cheng, Ramune Grambaite, Jūratė Šaltytė Benth & Christofer Lundqvist. (2024) Mortality and health-related quality of life in older adults with long-term use of opioids, z-hypnotics or benzodiazepines: a prospective observational study at 5 years follow-up. BMJ Open 14:2, pages e079347.
Crossref
Georgina A. Hughes, Maria C. Inacio, Debra Rowett, Catherine Lang, Robert N. Jorissen, Megan Corlis & Janet K. Sluggett. (2024) National Trends in Antidepressant Use in Australian Residential Aged Care Facilities (2006–2019). Journal of the American Medical Directors Association, pages 104957.
Crossref
E. A. Egorova, A. M. Beitullaev, A. V. Matveev & K. N. Koryanova. (2024) Review of publications on drug-related problems investigations in osteoporosis patients. Pharmacy & Pharmacology 11:5, pages 412-421.
Crossref
Mohammed Alharthi, David Wright, Sion Scott & Jeanette Blacklock. (2022) Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review. International Journal of Clinical Pharmacy 45:2, pages 304-319.
Crossref
Salvatore Crisafulli, Elisabetta Poluzzi, Carlotta Lunghi, Vincenzo Di Francesco, Luca Pellizzari, Luca Pasina, Chiara Elli, Francesco Trotta, Agnese Cangini, Caterina Trevisan, Maria Beatrice Zazzara, Graziano Onder & Gianluca Trifirò. (2022) Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective. Frontiers in Drug Safety and Regulation 2.
Crossref
Nicolay Jonassen Harbin, Morten Lindbæk & Maria Romøren. (2022) Barriers and facilitators of appropriate antibiotic use in primary care institutions after an antibiotic quality improvement program – a nested qualitative study. BMC Geriatrics 22:1.
Crossref
Raquel Díez, Raquel Cadenas, Julen Susperregui, Ana M. Sahagún, Nélida Fernández, Juan J. García, Matilde Sierra & Cristina López. (2022) Drug-Related Problems and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 19:7, pages 4313.
Crossref
Philip Stötzner, Rodolfo Enrique Ferrebus AbateJonathan Henssler, Magdalena Seethaler, Sandra Anna Just & Eva Janina Brandl. (2022) Structured Interventions to Optimize Polypharmacy in Psychiatric Treatment and Nursing Homes. Journal of Clinical Psychopharmacology 42:2, pages 169-187.
Crossref
Laura A. Dowd, Amanda J. Cross, Felicity Veal, Choon Ean Ooi & J. Simon Bell. (2022) A Systematic Review of Interventions to Improve Analgesic Use and Appropriateness in Long-Term Care Facilities. Journal of the American Medical Directors Association 23:1, pages 33-43.e3.
Crossref
Jaheeda Gangannagaripalli, Ian Porter, Antoinette Davey, Ignacio Ricci Cabello, Joanne Greenhalgh, Rob Anderson, Simon Briscoe, Carmel Hughes, Rupert Payne, Emma Cockcroft, Jim Harris, Charlotte Bramwell & Jose M Valderas. (2021) STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis. Health Services and Delivery Research 9:23, pages 1-118.
Crossref
Anne Sverdrup Efjestad, Hege Ihle-Hansen, Vidar Hjellvik, Knut Engedal & Hege Salvesen Blix. (2021) Sex differences in psychotropic and analgesic drug use before and after initiating treatment with acetylcholinesterase inhibitors. PLOS ONE 16:9, pages e0243804.
Crossref
D. Bonnan, F. Amouroux & M. Aulois-Griot. (2021) Le bilan partagé de médication: intérêt de la mise en place d’un nouveau service pharmaceutique dans la detection de problemes lies aux therapeutiques. Annales Pharmaceutiques Françaises 79:5, pages 597-603.
Crossref
Monica Sharma, Xin Yee Wong, J Simon Bell, Megan Corlis, Michelle Hogan & Janet K. Sluggett. (2021) Trajectories of pro re nata (PRN) medication prescribing and administration in long-term care facilities. Research in Social and Administrative Pharmacy 17:8, pages 1463-1468.
Crossref
Monika Lexow, Kathrin Wernecke, Gordian L. Schmid, Ralf Sultzer, Thilo Bertsche & Susanne Schiek. (2020) Considering additive effects of polypharmacy. Wiener klinische Wochenschrift 133:15-16, pages 816-824.
Crossref
A. V. Matveev, E. A. Egorova, E. I. Konyaeva, E. Yu. Bekirova & L. A. Adjimamutova. (2021) STUDY OF THE SAFETY OF ANTIANEMIC PREPARATIONS BY METHOD OF THE SYSTEM OF PROBLEMS RELATED TO MEDICINAL PREPARATIONS. Pharmacy & Pharmacology 9:1, pages 73-83.
Crossref
Aud Johannessen, Kjerstin Tevik, Knut Engedal & Anne-Sofie Helvik. (2020) Health professionals’ experience of nursing home residents’ consumption of alcohol and use of psychotropic drugs. Nordic Studies on Alcohol and Drugs 38:2, pages 161-174.
Crossref
Anne Spinewine, Perrine Evrard & Carmel Hughes. (2021) Interventions to optimize medication use in nursing homes: a narrative review. European Geriatric Medicine 12:3, pages 551-567.
Crossref
Mathilde Bories, Guillaume Bouzillé, Marc Cuggia & Pascal Le Corre. (2021) Drug–Drug Interactions in Elderly Patients with Potentially Inappropriate Medications in Primary Care, Nursing Home and Hospital Settings: A Systematic Review and a Preliminary Study. Pharmaceutics 13:2, pages 266.
Crossref
Amura Francesca Fog, Ibrahimu Mdala, Knut Engedal & Jørund Straand. (2020) Variation between nursing homes in drug use and in drug-related problems. BMC Geriatrics 20:1.
Crossref
Ulla L. Aalto, Hanna-Maria Roitto, Harriet Finne-Soveri, Hannu Kautiainen & Kaisu H. Pitkälä. (2019) Temporal Trends in the Use of Anticholinergic Drugs Among Older People Living in Long-Term Care Facilities in Helsinki. Drugs & Aging 37:1, pages 27-34.
Crossref
Amura Francesca Fog, Jørund Straand, Knut Engedal & Hege Salvesen Blix. (2019) Drug use differs by care level. A cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway. BMC Geriatrics 19:1.
Crossref
Anne Gerd Granas, Kjell Hermann Halvorsen, Julie Wendelbo & Cecilie Johannessen Landmark. (2019) Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities. International Journal of Clinical Pharmacy 41:6, pages 1516-1525.
Crossref
Mojtaba Vaismoradi, Flores Vizcaya Moreno, Hege Sletvold & Sue Jordan. (2019) PRN Medicines Management for Psychotropic Medicines in Long-Term Care Settings: A Systematic Review. Pharmacy 7:4, pages 157.
Crossref
Kjell H. Halvorsen, Torunn Stadeløkken & Beate H. Garcia. (2019) A Stepwise Pharmacist-Led Medication Review Service in Interdisciplinary Teams in Rural Nursing Homes. Pharmacy 7:4, pages 148.
Crossref
Alys W. Griffiths, Claire A. Surr, David P. Alldred, John Baker, Ruchi Higham, Karen Spilsbury & Carl A. Thompson. (2019) Pro re nata prescribing and administration for neuropsychiatric symptoms and pain in long-term care residents with dementia and memory problems: a cross-sectional study. International Journal of Clinical Pharmacy 41:5, pages 1314-1322.
Crossref
Ngit Yi Liew, Ying Yee Chong, Shiau Huey Yeow, Kok Pim Kua, Pui San Saw & Shaun Wen Huey Lee. (2019) Prevalence of potentially inappropriate medications among geriatric residents in nursing care homes in Malaysia: a cross-sectional study. International Journal of Clinical Pharmacy 41:4, pages 895-902.
Crossref
Anne Sverdrup Efjestad, Hege Ihle-Hansen, Vidar Hjellvik, Knut Engedal & Hege Salvesen Blix. (2019) Drug Use before and after Initiating Treatment with Acetylcholinesterase Inhibitors. Dementia and Geriatric Cognitive Disorders Extra 9:1, pages 196-206.
Crossref
Michael Dörks, Katharina Allers & Falk Hoffmann. (2019) Pro Re Nata Drug Use in Nursing Home Residents: A Systematic Review. Journal of the American Medical Directors Association 20:3, pages 287-293.e7.
Crossref
Yohanes Ayele, Kibkab Melaku, Mesay Dechasa, Mohammed Biset Ayalew & Boressa Adugna Horsa. (2018) Assessment of drug related problems among type 2 diabetes mellitus patients with hypertension in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia. BMC Research Notes 11:1.
Crossref